Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 21Observational 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Breast Neoplasms 15Prostatic Neoplasms 12Neoplasms 11Brain Neoplasms 10Lung Neoplasms 9Glioma 9Glioblastoma 9Carcinoma, Non-Small-Cell Lung 6Pancreatic Neoplasms 5Ovarian Neoplasms 5Colorectal Neoplasms 5Rectal Neoplasms 4Carcinoma, Hepatocellular 4Uterine Cervical Neoplasms 3Multiple Myeloma 3Esophageal Neoplasms 3Colonic Neoplasms 3Anus Neoplasms 3Urinary Bladder Neoplasms 2Thyroid Cancer, Papillary 2Small Cell Lung Carcinoma 2Recurrence 2Oligodendroglioma 2Neurotoxicity Syndromes 2Neuroendocrine Tumors 2Melanoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Leukemia, Myeloid, Acute 2

Interventions

Amplified Fragment Length Polymorphism Analysis 2Temozolomide 1Surveys and Questionnaires 1Specimen Handling 1Radiotherapy 1Pharmacogenomic Testing 1Microarray Analysis 1Magnetic Resonance Spectroscopy 1Immunohistochemistry 1Gene Expression Profiling 1Comparative Genomic Hybridization 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Gliosarcoma × Magnetic Resonance Spectroscopy × Clear all
NCT00777686 2012-03-30

Measuring Non-Enhancing Glioblastoma Progression

M.D. Anderson Cancer Center

Completed
7 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡